As a leading provider of disease management analytics and consulting services, we take an in-depth analytical approach to helping you design and implement your disease management program. Thomson Reuters expertise in this area is well regarded by organizations across the healthcare industry including public and private purchasers of healthcare, health plans and insurance carriers, state and federal government agencies, and providers around the country. Our disease management research findings and program analysis and development expertise and the results our customers have achieved with our support, have been recognized in The Wall Street Journal, The New York Times, USAToday, and many local and industry trade media.

Benefits

  • Based on an in-depth study of historical data on utilization and cost of medical and drug service, Thomson Reuters profiles populations to identify chronic manageable conditions and opportunities for improvement
  • Our claims grouping, clinical risk adjustment, and proven analytic methods enable customers to anticipate disease progression, predict future costs associated with a disease, and calculate return on investment
  • We apply our unsurpassed tools and methodologies to deliver a disease management solution tailored to your needs